Take a proactive approach to
treating myopia in children with
ACUVUE® Abiliti™ 1-Day
Soft Therapeutic Lenses
The ACUVUE® Abiliti™ portfolio aims to support children in an active lifestyle today and better eye health tomorrow.3,4
hydrogel lenses designed specifically for the pediatric eye to slow the progression of a child's myopia while correcting vision.*,2,5
Seeing the difference
Proven Efficacy:
Shown to reduce axial elongation by 0.105mm, on average in as little as 6 months.†,2
RingBoost™ Technology:
Breakthrough soft therapeutic lens innovation, featuring RingBoost™ technology, specifically targeted and designed for slowing the progression of myopia in children.5
Pediatric Eye-Inspired Design:
Designed to provide the comfort you expect from ACUVUE® OASYS 1-Day contact lenses with easy handling for children.‡,§,¶,2,6
Introducing RingBoost™ targeted technology
In typical dual focus soft contact lenses that are utilized for myopia management, the focal point generated for slowing eye growth is on the line of sight, which is seen to limit how strong the treatment power can be before the patient will have significant visual disturbance.5Abiliti™ 1-day lenses are a revolutionary innovation specifically targeted and designed for slowing the progression of myopia in children who are 7 to 12 years old at the start of treatment.5Johnson & Johnson Vision has developed this specialized optical design with novel RingBoost™ technology, in which the light passing through the outer treatment zones is focused in front of the retina but off the line of sight. This revolutionary technology is designed to break the interdependence between efficacy for slowing the progression of myopia and vision quality, seen as a limitation of dual focus and traditional multifocal lenses used for myopia management.5This means Abiliti™ 1-Day lenses can provide strong myopia treatment while maintaining vision quality. Typical multifocal or dual-focus lenses utilized for myopia management provide treatment power of no more than +3D along the line of sight5, whereas Abiliti™ 1-Day lenses with RingBoost™ technology provide treatment power with a +7D ring focus and a +10D central boost.5The unique optical properties of RingBoost™ technology are directly linked to the potential to slow the progression of myopia.5 In fact, in as little as 6 months, Abiliti™ 1-Day reduced axial elongation by 0.105mm on average.
Generally speaking, 0.18mm corresponds to approximately 0.5D of myopia.†,2
Generally speaking, 0.18mm corresponds to approximately 0.5D of myopia.†,2
Introducing SeeAbiliti™ app as part of our comprehensive treatment approach with the Abiliti™ portfolio
We offer the SeeAbiliti™ digital companion app for your patients and their parents to help at every step of their myopia management journey. With the latest resources, treatment support, and personalized tracking, the SeeAbiliti™ app helps track treatment plans and sustain behavioral changes in order to manage myopia.
With the Abiliti™ portfolio, the power is in your hands.
Together, we can take charge of myopia. Learn more about Johnson & Johnson Vision’s approach to clinical myopia management.
REFERENCES
*.Based on publicly available information as of December 3, 2021.
†.Compared to single vision contact lenses after 6 months wear.
‡.Utilizing a smaller lens diameter designed to fit the smaller anatomical features of a pediatric population (aged 7-12).
§.Handling tasks involved children inserting and removing their own contact lenses. Top 3 Box = Extremely easy, very easy, easy.
¶.ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management are manufactured using senofilcon A, the same material used to manufacture ACUVUE® OASYS 1-Day contact lenses.
1. JJV Data on File 2021. Mechanical Design of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management- Effect on Fit and Handling.
2. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses.
3. Santodomingo-Rubido, Jacinto, et al. Myopia control with orthokeratology contact lenses in Spain: a comparison of vision-related quality-of-life measures between orthokeratology contact lenses and single-vision spectacles. Eye &Contact Lens 39.2 (2013): 153-157.
4. Haarman AE et al. The complications of Myopia: A Review and Metaanalysis. Investigative Ophthalmology & Visual Science. 2020 Apr 9;61:49.
5. JJV Data on file, 2021. Development of Optical Design of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management.
6. JJV Data on file 2021. Stand-alone Performance Claims; ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management.
Important Safety information:
Acuvue® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management are available by prescription only for the correction of myopia (while the lenses are worn) and may slow the progression of myopia in children (7-12 years old). As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems. Due to the intended optical design of these lenses for the purpose of reducing the patient’s prescription change, these lenses will provide vision correction while worn, but the vision quality may not be as clear as with conventional soft contact lenses. Patients should exercise extra care if performing potentially hazardous, vision demanding activities. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or visit www.seeyourabiliti.com.
†.Compared to single vision contact lenses after 6 months wear.
‡.Utilizing a smaller lens diameter designed to fit the smaller anatomical features of a pediatric population (aged 7-12).
§.Handling tasks involved children inserting and removing their own contact lenses. Top 3 Box = Extremely easy, very easy, easy.
¶.ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management are manufactured using senofilcon A, the same material used to manufacture ACUVUE® OASYS 1-Day contact lenses.
2. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses.
3. Santodomingo-Rubido, Jacinto, et al. Myopia control with orthokeratology contact lenses in Spain: a comparison of vision-related quality-of-life measures between orthokeratology contact lenses and single-vision spectacles. Eye &Contact Lens 39.2 (2013): 153-157.
4. Haarman AE et al. The complications of Myopia: A Review and Metaanalysis. Investigative Ophthalmology & Visual Science. 2020 Apr 9;61:49.
5. JJV Data on file, 2021. Development of Optical Design of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management.
6. JJV Data on file 2021. Stand-alone Performance Claims; ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management.
Acuvue® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management are available by prescription only for the correction of myopia (while the lenses are worn) and may slow the progression of myopia in children (7-12 years old). As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems. Due to the intended optical design of these lenses for the purpose of reducing the patient’s prescription change, these lenses will provide vision correction while worn, but the vision quality may not be as clear as with conventional soft contact lenses. Patients should exercise extra care if performing potentially hazardous, vision demanding activities. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or visit www.seeyourabiliti.com.
PP2021ABL4042
REFERENCES
